Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiv Kumar Sarin

Showing results (301-310 of 365) with videos related to

Pageof 37
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 13, 2026
Liver kinome reveals PS1145 as therapeutic agent for mitigating systemic inflammation in alcohol-related liver diseaseManisha Yadav, Abhishak Gupta, Sanju Yadav, et al.
Ultrasound in Medicine & Biology|May 18, 2024
WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound ElastographyGiovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, et al.
Journal of Hepatology|March 30, 2023
Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimodSukriti Baweja, Anupama Kumari, Preeti Negi, et al.
Hepatology International|May 23, 2022
ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort studyChuan Liu, Jia Li, Yu Jun Wong, et al.
Hepatology International|February 22, 2019
Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in IndiaAjit Sood, Ajay Duseja, Mayank Kabrawala, et al.
Hepatology International|August 12, 2009
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatmentShiv Kumar Sarin, Ashish Kumar, Yogesh Kumar Chawla, et al.
Hepatology International|July 9, 2021
Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)Akash Shukla, Ananta Shreshtha, Amar Mukund, et al.
Vaccines|January 22, 2022
Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare WorkersPratibha Kale, Ekta Gupta, Chhagan Bihari, et al.
BMJ Open|April 7, 2022
Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)Meenu Bajpai, Ashish Maheshwari, Vikas Dogra, et al.
Hepatology International|June 17, 2025
Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysisJing Chen, Dong Ji, Jidong Jia, et al.
Pageof 37

Showing results (301-310 of 365) with videos related to

Sort By:
Pageof 37
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 13, 2026
Liver kinome reveals PS1145 as therapeutic agent for mitigating systemic inflammation in alcohol-related liver diseaseManisha Yadav, Abhishak Gupta, Sanju Yadav, et al.
Ultrasound in Medicine & Biology|May 18, 2024
WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound ElastographyGiovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, et al.
Journal of Hepatology|March 30, 2023
Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimodSukriti Baweja, Anupama Kumari, Preeti Negi, et al.
Hepatology International|May 23, 2022
ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort studyChuan Liu, Jia Li, Yu Jun Wong, et al.
Hepatology International|February 22, 2019
Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in IndiaAjit Sood, Ajay Duseja, Mayank Kabrawala, et al.
Hepatology International|August 12, 2009
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatmentShiv Kumar Sarin, Ashish Kumar, Yogesh Kumar Chawla, et al.
Hepatology International|July 9, 2021
Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)Akash Shukla, Ananta Shreshtha, Amar Mukund, et al.
Vaccines|January 22, 2022
Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare WorkersPratibha Kale, Ekta Gupta, Chhagan Bihari, et al.
BMJ Open|April 7, 2022
Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)Meenu Bajpai, Ashish Maheshwari, Vikas Dogra, et al.
Hepatology International|June 17, 2025
Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysisJing Chen, Dong Ji, Jidong Jia, et al.
Pageof 37